Aridis Pharmaceuticals, Inc.
SEC CIK 1614067 · ARDS] · last insider filing 2024-06-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hamilton John F | Director | filed 2018 - 2024 |
| Windham-Bannister Susan Richards | Director | filed 2019 - 2024 |
| Patzer Eric | Director · Executive Chairman | filed 2018 - 2024 |
| Truong Vu | Director · Chief Executive Officer | filed 2018 - 2024 |
| Ruffolo Robert R | Director | filed 2018 - 2022 |
| Gibbs Craig S | Director | filed 2018 - 2022 |
| Lu Shawn | Director | filed 2018 - 2018 |
| Coughlin Robert K. | Director | filed 2018 - 2018 |
| Blech Isaac | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jafri Hasan | Chief Medical Officer | filed 2020 - 2024 |
| Kurland Fred | Chief Financial Officer | filed 2018 - 2023 |
| Nazak Michael Adrian | Chief Financial Officer | filed 2020 - 2021 |
| Dummer Wolfgang | Chief Medical Officer | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.